###begin article-title 0
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1</italic>
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1</italic>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
Genetic polymorphisms in DNA repair genes may influence individual variation in DNA repair capacity, which may be associated with risk of developing cancer. For colorectal cancer the importance of mutations in mismatch repair genes has been extensively documented. Less is known about other DNA repair pathways in colorectal carcinogenesis. In this study we have focused on the XRCC1, XRCC3 and XPD genes, involved in base excision repair, homologous recombinational repair and nucleotide excision repair, respectively.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">194</sup>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 201 207 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
We used a case-control study design (157 carcinomas, 983 adenomas and 399 controls) to test the association between five polymorphisms in these DNA repair genes (XRCC1 Arg194Trp, Arg280His, Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln), and risk of colorectal adenomas and carcinomas in a Norwegian cohort. Odds ratio (OR) and 95% confidence interval (95% CI) were estimated by binary logistic regression model adjusting for age, gender, cigarette smoking and alcohol consumption.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
The XRCC1 280His allele was associated with an increased risk of adenomas (OR 2.30, 95% CI 1.19-4.46). The XRCC1 399Gln allele was associated with a reduction of risk of high-risk adenomas (OR 0.62, 95% CI 0.41-0.96). Carriers of the variant XPD 751Gln allele had an increased risk of low-risk adenomas (OR 1.40, 95% CI 1.03-1.89), while no association was found with risk of carcinomas.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
Our results suggest an increased risk for advanced colorectal neoplasia in individuals with the XRCC1 Arg280His polymorphism and a reduced risk associated with the XRCC1 Arg399Gln polymorphism. Interestingly, individuals with the XPD Lys751Gln polymorphism had an increased risk of low-risk adenomas. This may suggest a role in regression of adenomas.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
In Western populations the vast majorities of colorectal cancers (CRC) arise from benign adenomatous polyps (colorectal adenomas) and evolve through the adenoma-carcinoma sequence, a multistep process of genetic alterations [1,2]. The lifetime risk of CRC in a normal population is low in comparison to the prevalence of adenomas. This indicates that only a few of the adenomas will develop into a carcinoma. However, from the perspective of understanding the genetic events involved in colonic neoplasia, these early lesions are valuable endpoints.
###end p 11
###begin p 12
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 940 953 940 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1, XRCC3 </italic>
###xml 957 961 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
The risk of sporadic CRC is associated with lifestyle factors like cigarette smoking and alcohol consumption which may be modulated by several genetic factors of low penetrance [3,4]. Cigarette smoke and alcohol may act as sources of chemical carcinogens (including nitrosamines, heterocyclic amines and polycyclic hydrocarbons), reactive oxygen species (ROS) [5,6] and DNA adduct formation [3]. Genetic polymorphisms in DNA repair genes may influence individual variation in DNA repair capacity, which may be associated with risk of developing cancer [7]. During the past years, an increasing number of DNA repair gene polymorphisms have been described and their involvement in carcinogenesis investigated. For colorectal cancer, the importance of mutations in mismatch repair (MMR) genes has been extensively documented. Less is known about other DNA repair pathways in colorectal carcinogenesis, and in this study we have focused on the XRCC1, XRCC3 and XPD genes.
###end p 12
###begin p 13
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
The DNA repair gene XRCC1 gene codes for a protein involved in the repair of single-strand breaks (SSB) and in base excision repair (BER) of damaged bases caused by endogenous and exogenous oxidants. Three polymorphisms occurring at conserved sequences in the XRCC1 gene were reported by Shen et al. [8]. These coding polymorphisms, resulting in amino acid substitutions, were detected at codons 194 (Arg-Trp), 280 (Arg-His) and 399 (Arg-Gln). Most studies report a reduced risk of cancer associated with the 194Trp allele [9]. The 399 polymorphism have been associated with a number of cancers, although results have been inconsistent [9-15]. Few studies have investigated the association between the XRCC1 280His allele and risk of cancer. No association has been observed with colorectal cancer [13], but an increased risk has been reported with lung cancer [16] and breast cancer [17].
###end p 13
###begin p 14
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
The XRCC3 gene codes for a protein involved in homologous recombinational repair (HRR) of double-strand DNA and is required for genomic stability [18,19]. The XRCC3 gene has a sequence variation in exon 7 (C18067T), which results in an amino acid substitution at codon 241 (Thr241Met) that may affect the enzyme's function and/or its interaction with other proteins involved in DNA damage and repair [20]. Molecular epidemiological studies have linked this XRCC3 polymorphism to increased risk of breast cancer [21], lung cancer [22], skin cancer [23] and colorectal cancer [14]. The results have been inconsistent [24].
###end p 14
###begin p 15
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 494 497 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 566 567 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 644 648 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 838 840 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 841 843 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 964 966 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 967 969 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The XPD protein is involved in the nucleotide excision repair (NER) pathway [25], which recognizes and repairs a wide range of structurally unrelated lesions such as bulky adducts and thymidine dimers [26-28]. The XPD gene encodes a helicase that is a component of the transcription factor TFIIH [29]. Mutations in the XPD gene can diminish the activity of TFIIH complexes increasing the likelihood of repair defects, transcription defects, and abnormal responses to apoptosis [30]. The XPD Lys751Gln substitution is attributed to a (A-->C) transversion at exon 23 [8]. Several epidemiological studies have investigated the association between XPD polymorphisms and cancer. Smoking related cancers and skin cancers are most frequently investigated, but it is not yet established whether the polymorphism is linked to risk of lung cancer [31,32]. No association has been observed with the various stages of the adenoma-carcinoma sequence or with colorectal cancer [14,15].
###end p 15
###begin p 16
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">194</sup>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
In the present study we used a case-control design to test the association between five amino acid substitution variants of DNA repair genes, XRCC1 (Arg194Trp), XRCC1 (Arg280His), XRCC1 (Arg399Gln), XRCC3 (Thr241Met) and XPD (Lys751Gln), and colorectal adenoma/cancer risk in a Norwegian cohort. The main focus was to investigate if these polymorphisms are linked to risk of colorectal adenoma and carcinoma. By studying repair genes in the various stages of the adenoma-carcinoma sequence we may gain new information on the significance of polymorphisms in neoplastic tissues during transition.
###end p 16
###begin title 17
Methods
###end title 17
###begin p 18
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
The cohort in the KAM (Kolorektal cancer, Arv og Miljo) molecular epidemiological study is based on the screening group of the Norwegian Colorectal Cancer Prevention study (The NORCCAP study) in the county of Telemark [33]. The ID number for the NORCCAP study at ClinicalTrials.gov is NCT00119912 [34]. In addition, patients diagnosed with colorectal cancer, operated on at Telemark Hospital (Skien) and Ulleval University Hospital (Oslo) were included. The KAM cohort is based on an ethnic homogeneous group of Norwegian origin.
###end p 18
###begin p 19
###xml 319 331 <span type="species:ncbi:9606">participants</span>
The KAM biobank consists of blood and tissue samples from 1044 individuals identified with adenomas in the large intestine (991 high- and low-risk adenomas, 53 hyperplastic polyps), 160 with colorectal cancer and 400 controls, defined as individuals with normal findings at flexible sigmoidoscopy screening. All of the participants completed a questionnaire on demographics, health status, dietary; and smoking habits, alcohol consumption, physical exercise and occupation. The questionnaire contained information on a family history of adenomas and carcinomas, and the included cases and controls had no known personal history of genetic predisposition. The KAM study is approved by the Regional Ethics Committee and the Data Inspectorate.
###end p 19
###begin p 20
###xml 319 321 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
In the present study we analyzed available blood samples from 157 cases with carcinoma, 983 cases with adenomas, (i.e. 227 high-risk and 756 low-risk adenomas) and 399 controls. A high-risk adenoma is defined as an adenoma measuring >/= 10 mm in diameter and/or with villous components and/or showing severe dysplasia [33].
###end p 20
###begin p 21
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The distribution of age, gender, cigarette smoking and alcohol consumption among controls and cases with colonic carcinomas and adenomas are shown in Table 1.
###end p 21
###begin p 22
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Genomic DNA was isolated from blood samples according to standard procedures [35] with minor modifications. In brief, whole blood samples (anticoagulated) was mixed with a threefold volume of lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 1 mM EDTA pH 7.4) and incubated at 4degreesC for at least 30 min. The lysate was then centrifuged, and pellet of intact leukocytes was resuspended in 10 ml SE buffer (75 mM NaCl, 24 mM EDTA pH 8.0) 500 mul SDS (20 %) and 50 mul Proteinase K (20 mg/ml) and incubated overnight at 40degreesC. After digestion, 3.5 ml 6 M NaCl was added to the lysate and the mixture was shaken vigorously and then centrifuged to pellet the cellular proteins. DNA in the supernatant was then precipitated with 2 volumes of absolute ethanol, washed in 70 % ethanol and resuspended in TE buffer (10 mM TrisHCl, 0.1 mM EDTA, pH 7.5).
###end p 22
###begin p 23
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 242 248 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">194</sup>
###xml 293 299 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 302 305 302 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 330 333 330 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 664 665 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 671 677 646 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 680 683 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 703 707 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 710 713 685 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 770 772 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 773 775 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
Genotype analysis of the five single nucleotide polymorphisms (SNPs) of the DNA repair genes XRCC1, XRCC3 and XPD was carried out using the TaqMan allelic discrimination assay on a Sequence Detection System ABI 7000 (Applied Biosystems). The XRCC1 polymorphisms (XRCC1 Arg194Trp (rs#1799782), XRCC1 Arg280His (rs#25489), XRCC1 Arg399Gln (rs#25487)) were determined in 12 mul reactions containing 1x MasterMix, 200 nM of each probe, 900 nM primers, and 50-100 ng of genomic DNA. Cycling conditions were as follows: 50degreesC for 2 min, 95degreesC for 10 min, and 45 cycles of 95degreesC for 15 s and 60degreesC for 1 min. Primers and probes are described in Table 2. The XRCC3 Thr241Met (rs#861539) and XPD Lys751Gln (rs#1052559) were genotyped as described previously [24,36]. Controls were included in each run and repeated genotyping of a random 10 % subset yielded 100 % identical genotypes.
###end p 23
###begin p 24
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 767 768 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 824 827 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 835 841 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 844 847 844 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 914 915 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
SPSS (Statistical Packages for the Social Sciences) 12.0.1 for Windows was used for the statistic calculations. Odds ratios (OR) and 95 % confidence intervals (CI) were calculated using binary logistic regression to assess the relationship between each polymorphism and the colorectal adenoma or carcinoma cases. Two separate ORs were calculated, one adjusted for age only (Table 3), and the other for age, gender, cigarette smoking (number of cigarette years) and alcohol consumption (units of alcohol per month) (Table 4). Due to missing data on cigarette smoking and alcohol consumption (67 controls, 51 carcinomas and 156 adenomas) the number of case and controls used to calculate OR adjusted for age, gender, cigarette smoking and alcohol consumption (in Table 4) is reduced. Possible combined effects of the XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms were investigated in a two by three table (Table 5).
###end p 24
###begin p 25
###xml 171 177 171 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
Given the allele frequency of polymorphism of the controls and assuming Hardy-Weinberg equilibrium, we had a 65 % chance (at the 5 % level) of detecting an OR of 2.25 for XRCC1 codon 280 heterozygotes among high-risk adenomas and 81 % among low-risk adenomas. We had 60 % chance of detecting an OR of 0.65 among carriers of the variant allele of XRCC1 codon 399 among high-risk adenomas and 81 % among low-risk adenomas. For the XPD codon 751 polymorphism, we had 54 % chance of detecting an OR of 1.36 and 1.55 among heterozygote and homozygote carriers among high-risk adenomas and 79 % power among low-risk adenomas.
###end p 25
###begin p 26
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 441 447 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
Haplotypes were estimated and ORs calculated using the Hplus program available online [37]. Hplus is a SNP analysis tool for performing haplotype estimation according to the distribution of genotypes in a population. Such haplotype-based methods should be used either for multiple SNPs within candidate genes or when selected SNPs are physically closed to each other [38]. We used this method to estimate haplotypes of three SNPs within the XRCC1 gene.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 574 580 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 741 746 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1</italic>
###xml 748 754 748 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
The genotypic distributions of the five polymorphisms in the three DNA repair genes for both cases and controls are shown in Table 3. The frequencies for the XRCC1 194Trp allele, XRCC1 280His allele, XRCC1 399Gln allele, XRCC3 241Met allele and XPD 751Gln allele among the controls were respectively, 0.06, 0.02, 0.39, 0.40 and 0.34. The genotype distributions were all in Hardy-Weinberg equilibrium and the distributions of the alleles in the control group are in agreement with those found in other Caucasian populations [9], and in other Scandinavian populations for the XRCC3 241Met allele and XPD 751Gln allele [24,36]. Tables 3 and 4 also presents the estimates of ORs of colorectal adenomas and carcinomas associated with the various XRCC1, XRCC3 and XPD polymorphisms.
###end p 28
###begin p 29
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 529 535 529 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 620 626 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 732 738 732 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 767 773 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
The XRCC1 280His allele was associated with an increased risk of adenomas with OR of 2.30 (95% CI 1.19-4.46) (OR 3.82, 95% CI 1.59-9.18 and OR 2.07, 95 % CI 1.05-4.10 for high- and low-risk adenomas, respectively). Among the carcinoma cases the same trend was observed although not significant. The XRCC1 399Gln allele showed a trend towards risk reduction for carcinomas and adenomas, reaching statistical significance only for the high-risk adenomas, OR of 0.62 (95% CI 0.41-0.96). There was no significant association between XRCC1 194Trp allele and risk of colorectal adenomas and carcinomas. The combination of the XRCC1 codon 280 and XRCC1 codon 399 polymorphisms showed a significant positive association for carriers of the XRCC1 codon 280 variant allele and XRCC1 codon 399 wild type allele, in the high-risk adenomas only, OR of 2.92 (95 % CI 1.20-7.10).
###end p 29
###begin p 30
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
No significant association was found between the XRCC3 Thr241Met polymorphism and risk of colorectal adenomas and carcinomas.
###end p 30
###begin p 31
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
Further, no significant association was found between the XPD Lys751Gln polymorphism and colorectal cancer. There was, however, a significant association between the XPD 751Gln allele and risk of adenomas with OR of 1.42 (95% CI 1.06-1.89). This association was limited to the low-risk adenoma group OR of 1.40 (95% CI 1.03-1.89).
###end p 31
###begin p 32
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
No statistical significant associations were found between the haplotypes estimated in the XRCC1 gene and adenoma or carcinoma risk (further data not shown).
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
In this case-control study we investigated the role of polymorphisms, that result in amino acid substitution, of three DNA repair genes involved in NER, BER and HRR.
###end p 34
###begin p 35
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 881 886 881 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
In this study we did not find an association between the XPD Lys751Gln polymorphism and colorectal carcinoma, but we did find an association between the XPD 751Gln allele and colorectal adenomas, especially with the low-risk adenomas (OR 1.40, 95 % CI 1.03-1.89). Lack of association with the cancer group and the high-risk adenoma group, may be due to small sample size. Another explanation for the observed association in the low-risk adenoma group could be that the polymorphism may play a role in regression of adenomas rather than progression to high-risk adenomas and cancer (advanced neoplasia). Although, it is generally assumed that adenomas grow into cancer or remain in the colon until death, epidemiological data suggests that less than 5 % of adenomas may progress to carcinoma in a lifetime and spontaneous regression of adenomas has been reported [[39-41]]. Hofstad et al. [40] have reported that 60 % of adenomas with diameters less than 10 mm stop growing or go into regression within 3 years of observation. In our material, 63 % of cases with low-risk adenomas were hetero- or homozygous for this polymorphism. However, the characteristics of adenomas going into regression are not known.
###end p 35
###begin p 36
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 619 622 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 737 741 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
Our results indicate that the XPD Lys751Gln polymorphism may predispose slightly to development of colorectal adenomas or that the polymorphism may be of importance for arresting the adenoma-carcinoma sequence in the low-risk phase and facilitate regression of adenomas. Large prospective studies would be required to clarify this issue. XPD polymorphisms have been analyzed particularly in epidemiological studies on skin and smoking-related cancers and no obvious relationship has been found for these types of cancers. Mort et al. [14] and Yeh et al. [15] have reported no significant association between the XPD Lys751Gln polymorphism and colorectal cancer. To our knowledge no studies have been published on the association between XPD polymorphisms and colorectal adenomas.
###end p 36
###begin p 37
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
We found no significant association between the XRCC1 194Trp allele and colorectal adenoma or carcinoma risk. This is not in agreement with the results reported by Abdel-Rahman et al. [12], but consistent with the results reported by Hong et al. [13].
###end p 37
###begin p 38
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OGG1 </italic>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">326</sup>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 547 553 547 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OGG1 </italic>
In our study, the XRCC1 399Gln allele was associated with a slightly decreased risk of colorectal adenomas and carcinomas, although statistically significant only for the high-risk adenomas, (OR 0.62, 95% CI 0.41-0.96). This protective role of the XRCC1 399Gln allele is in contrast to previous reports [12,13] on this BER gene polymorphism and colorectal cancer risk. Previously, we reported a reduced risk of colorectal adenomas and cancer in association with another BER gene polymorphism, the OGG1 Ser326Cys [42]. We have therefore tested the XRCC1 codon 399 and OGG1 codon 326 variant alleles in combination, but it showed no significant association with colorectal adenoma or cancer risk (OR 1.18, 95% CI 0.38-3.68; OR 0.91, 95% CI 0.54-1.52) (further data not shown).
###end p 38
###begin p 39
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 617 623 617 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 890 896 890 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 899 902 899 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 1373 1379 1373 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1393 1399 1393 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1453 1459 1453 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1512 1518 1512 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1550 1556 1550 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1570 1576 1570 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1710 1716 1710 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 1819 1825 1819 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
In this study we identified an association between the XRCC1 280His allele and risk of colorectal adenomas and carcinomas, but again, this increased risk was only significant for the adenomas (OR 2.30, 95% CI 1.19-4.46). As far as we know, the KAM study is the first reporting an association between the XRCC1 Arg280His polymorphism and colorectal adenoma and carcinoma risk. There are few reports on this polymorphism. In 1999, Lunn et al. [43] examined the relationship of XRCC1 genotypes and different levels of aflatoxin B1-DNA adducts (51 controls and 69 cases), but no significant effects were observed for the XRCC1 280His allele. Recently, Hong et al. [13] reported an association between the 280His allele and colorectal cancer in combination with the 194Arg allele and the 399Arg allele (OR 1.78, 95 % CI 1.09-2.89). Takanami et al. [44] have reported results suggesting that the XRCC1 Arg280His variant protein has an ineffective or reduced ability to localize a damaged site in the chromosome, thereby reducing the cellular BER/SSB repair efficiency. The variant 280His allele may allow un-repaired SSBs to accumulate, thereby accelerating genomic instability which consequently increases the risk of carcinogenesis. This is supported by our findings of an association between a variant 280His allele and high-risk adenomas. We found that the two polymorphisms XRCC1 Arg280His and XRCC1 Arg399Gln were linked such that the variant allele of XRCC1 codon 280 co-segregated with the wild type allele of XRCC1 codon 399 (p = 0.045). When the XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms were combined, the effects of the polymorphisms appeared independently of each other. The variant carriers of XRCC1 codon 399 were not statistically significantly, but consistently, at decreased risk of cancer, whereas XRCC1 codon 280 heterozygotes were at increased risk of cancer.
###end p 39
###begin p 40
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
No significant association was found between the XRCC3 Thr241Met polymorphism and colorectal adenomas or carcinomas in our study. This XRCC3 codon 241 polymorphism has previously shown a significant association with colorectal cancer risk [14] (OR 1.52, 95% CI 1.04-2.22) while in another study no association was detected [15]. One study reports no association between this XRCC3 polymorphism and colorectal adenoma risk [45]. High alcohol consumption has been linked to increased risk of colorectal neoplasia caused by an antifolate effect, resulting in uracil misincorporation into DNA and chromosomal breaks [46].
###end p 40
###begin p 41
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
We have tested the combination of the XRCC3 codon 241 variant allele and alcohol consumption but it showed no significant association with colorectal adenoma or carcinoma risk (OR 1.00, 95% CI 0.98-1.02; OR 0.96, 95% CI 0.92-1.00) (further data not shown). We have also tested the interaction between each of the five DNA repair polymorphisms and cigarette smoking, but they showed no significant association with colorectal adenoma or carcinoma (further data not shown). These results are in agreement with other published studies [45,47]. To the best of our knowledge, contrary to genetic factors such as metabolic genetic polymorphisms, few studies suggest that the genetic polymorphisms of DNA repair genes may interact with environmental factors such as alcohol drinking and cigarette smoking [3,9].
###end p 41
###begin p 42
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1</italic>
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 967 973 967 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
The divergence in results from different studies on XRCC1, XRCC3 and XPD polymorphisms may be related to variation in carcinogenic exposure and ethnic origin of the studied populations. Too small sample size and/or the inadequate controlling for certain confounders such as age, gender, alcohol consumption and cigarette smoking may contribute to differing results. It is possible that some of the candidate genes only contribute to colorectal cancer development in combination with certain dietary and /or lifestyle factors. Interaction between various gene products may increase cancer risk. A combination of polymorphisms in these genes may have additive or synergistic effects. For polymorphisms not showing an obvious association with colorectal adenoma or cancer when studied separately, an association with colorectal adenoma or cancer is still possible in combination with other polymorphisms. We have tested the combination of the three polymorphisms in the XRCC1 gene but none of the estimated haplotypes showed a significant association with colorectal adenoma or carcinoma risk.
###end p 42
###begin p 43
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
The design of this study is relatively strong because the controls were recruited from the same cohort as the adenoma and carcinoma cases. The CRC cases and controls have not been matched by age which may affect the results in a study. However, our controls have been screened and found polyp free and the risk of any of them having colon cancer at the time of inclusion is not very likely. The definition of polyp-free controls was based on a negative flexible sigmoidoscopy screening examination. It has been estimated that the risk of erroneously classifying individuals with proximal advanced neoplasia as neoplasia-free is less than 3 % at flexible sigmoidoscopy [48,49]. Therefore, the risk of misclassification appears small, and it may only contribute to a type II statistical error, reducing the difference between case groups and controls. It cannot be excluded that the present findings are due to chance. The relatively small numbers of the CRC cases, and the low frequency of the variant allele for at least some of the polymorphisms limited our power to detect an assosiation with risk of adenomas and carcinomas.
###end p 43
###begin title 44
Conclusion
###end title 44
###begin p 45
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
###xml 412 420 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 159 166 <span type="species:ncbi:9606">persons</span>
In conclusion, our results suggest an increased risk for advanced colorectal neoplasia in individuals with XRCC1 Arg280His polymorphism and a reduced risk for persons with XRCC1 Arg399Gln. The increased risk of having low-risk adenomas in contrast to advanced neoplasia for individuals with XPD Lys751Gln polymorphism may suggest a role in regression of adenomas and should be explored in prospective studies of in situ adenomas.
###end p 45
###begin title 46
Competing interests
###end title 46
###begin p 47
The author(s) declare that they have no competing interests.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
CFS established the methods in the lab and performed the genotyping analysis of the XRCC1 and XRCC3 genes and prepared the first draft of the paper. She did the data analysis. MS prepared samples for analysis. She also contributed to the manuscript and with advice on data analysis. PCH contributed with statistical advice. SA and IMBL contributed with the pathology of the cancer cases. EJ participated in the collection of blood samples and questionnaires from the cancer cases. ILH participated in collection and quality control of the questionnaires. UBV contributed with genotyping of the XPD gene and together with CFS, MS and EHK interpreted the results. EHK brought the idea of the KAM study and organized it. She was also responsible for the revisions of the manuscript. All authors discussed the results, contributed to interpretation of the results and the final manuscript.
###end p 49
###begin title 50
Pre-publication history
###end title 50
###begin p 51
The pre-publication history for this paper can be accessed here:
###end p 51
###begin p 52

###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
This study was supported by the Norwegian Cancer Society (Grant numbers 51024/001 and E01-0851001), Telemark University College (Grant number 22069), the Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grants from the Norwegian Cancer Society and the Department of Health and Social Affairs), with the aid of EXTRA funds from the Norwegian Foundation for Health and Rehabilitation (2001/2/0110), Eastern Norway Regional Health Authority, the Danish Research Agency (Grant numbers 22-02-0356 and 2052-03-0016) and DRAGE, a grant from Danish Ministry of Health, Research Center for Environmental Health's Fund.
###end p 54
###begin p 55
We thank Gunter Bock for collecting tumor tissues and Dr. Geir Hoff for critically reviewing the manuscript.
###end p 55
###begin article-title 56
A genetic model for colorectal tumorigenesis
###end article-title 56
###begin article-title 57
Lessons from hereditary colorectal cancer
###end article-title 57
###begin article-title 58
Colorectal cancer: molecules and populations
###end article-title 58
###begin article-title 59
Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility
###end article-title 59
###begin article-title 60
DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk
###end article-title 60
###begin article-title 61
Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas
###end article-title 61
###begin article-title 62
Polymorphisms in DNA repair and environmental interactions
###end article-title 62
###begin article-title 63
###xml 111 117 <span type="species:ncbi:9606">humans</span>
Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans
###end article-title 63
###begin article-title 64
Polymorphisms in DNA repair genes and associations with cancer risk
###end article-title 64
###begin article-title 65
No association between base excision repair gene polymorphisms and risk of lung cancer
###end article-title 65
###begin article-title 66
A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55
###end article-title 66
###begin article-title 67
Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt
###end article-title 67
###begin article-title 68
Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer
###end article-title 68
###begin article-title 69
Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer
###end article-title 69
###begin article-title 70
Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan
###end article-title 70
###begin article-title 71
Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk
###end article-title 71
###begin article-title 72
Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy
###end article-title 72
###begin article-title 73
Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation
###end article-title 73
###begin article-title 74
The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells
###end article-title 74
###begin article-title 75
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects
###end article-title 75
###begin article-title 76
Variants in DNA double-strand break repair genes and breast cancer susceptibility
###end article-title 76
###begin article-title 77
XRCC3 polymorphisms and risk of lung cancer
###end article-title 77
###begin article-title 78
A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer
###end article-title 78
###begin article-title 79
No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer
###end article-title 79
###begin article-title 80
DNA excision repair pathways
###end article-title 80
###begin article-title 81
Repair of DNA lesions: mechanisms and relative repair efficiencies
###end article-title 81
###begin article-title 82
###xml 135 140 <span type="species:ncbi:9606">human</span>
Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene
###end article-title 82
###begin article-title 83
Molecular mechanism of nucleotide excision repair
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human xeroderma pigmentosum group D gene encodes a DNA helicase
###end article-title 84
###begin article-title 85
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH
###end article-title 85
###begin article-title 86
ERCC2/XPD gene polymorphisms and cancer risk
###end article-title 86
###begin article-title 87
ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review
###end article-title 87
###begin article-title 88
The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years
###end article-title 88
###begin article-title 89
ClinicalTrials.gov
###end article-title 89
###begin article-title 90
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 90
###begin article-title 91
Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer
###end article-title 91
###begin article-title 92
Hplus
###end article-title 92
###begin article-title 93
A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies
###end article-title 93
###begin article-title 94
Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection
###end article-title 94
###begin article-title 95
Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years
###end article-title 95
###begin article-title 96
National Polyp Study data: evidence for regression of adenomas
###end article-title 96
###begin article-title 97
GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer
###end article-title 97
###begin article-title 98
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency
###end article-title 98
###begin article-title 99
The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability
###end article-title 99
###begin article-title 100
XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma
###end article-title 100
###begin article-title 101
Folate, methionine, and alcohol intake and risk of colorectal adenoma
###end article-title 101
###begin article-title 102
The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population
###end article-title 102
###begin article-title 103
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380
###end article-title 103
###begin article-title 104
Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
###end article-title 104
###begin title 105
Figures and Tables
###end title 105
###begin p 106
Distributions of age, gender, cigarette smoking and alcohol consumption among controls and cases with colorectal carcinomas and adenomas.
###end p 106
###begin p 107
* Missing values for cigarette smoking and alcohol consumption gave rise to diminished number of cases and controls.
###end p 107
###begin p 108
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4 </sup>
a There are significant differences in the number of males and females in the control group and the case groups, p < 10-4 (test for comparison of two proportions).
###end p 108
###begin p 109
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4 </sup>
b There are significant differences in age among the control group and the case groups, p < 10-4 (Mann-Whitney test).
###end p 109
###begin p 110
Design of primers and TaqMan probes for allelic discrimination assay.
###end p 110
###begin p 111
The bold underlined letters represent the polymorphic positions.
###end p 111
###begin p 112
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">194</sup>
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
Distributions of XRCC1 Arg194Trp, XRCC1 Arg280His, XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln genotypes and development of colorectal carcinomas and adenomas. ORs are adjusted for age.
###end p 112
###begin p 113
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a The genotype served as reference category
###end p 113
###begin p 114
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">194</sup>
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC3 </italic>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">241</sup>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPD </italic>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">751</sup>
Distributions of XRCC1 Arg194Trp, XRCC1 Arg280His, XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln genotypes and development of colorectal carcinomas and adenomas. ORs are adjusted for age, gender, cigarette smoking and alcohol consumption.
###end p 114
###begin p 115
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a The genotype served as reference category
###end p 115
###begin p 116
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">280</sup>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1 </italic>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">399</sup>
Combinations of XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms and risk of colorectal carcinomas and adenomas. ORs are adjusted for age.
###end p 116
###begin p 117
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a The genotype served as a reference category
###end p 117

